Showing 4381-4390 of 21464 results for "".
- Diversity in Clinical Trials: Innovative Recruitment Strategies for Psoriasis Researchhttps://reachmd.com/news/diversity-in-clinical-trials-innovative-recruitment-strategies-for-psoriasis-research/2473903/Diversity in clinical trials is critical, especially for psoriasis studies focusing on patients of varied skin tones. Effective
- Innovative Models for Personalized Brain Tumor Therapy: The Future of Oncologyhttps://reachmd.com/news/innovative-models-for-personalized-brain-tumor-therapy-the-future-of-oncology/2471385/Recent advancements in brain tumor research are paving the way for personalized cancer treatments that mimic the original tumors more closely than ever before, offering new hope for patients with challenging conditions like glioblastoma. Revolu
- Childhood Trauma and Neighborhood Conditions Impact Injury Recovery in Black Menhttps://reachmd.com/news/childhood-trauma-and-neighborhood-conditions-impact-injury-recovery-in-black-men/2471381/A recent study from the University of Pennsylvania School of Nursing, published in the Journal of Urban Health, examines how early-life trauma and neighborhood conditions affect the mental health recovery of Black men in Phi
- Subcortical Shape Alterations Reveal New Insights into Parkinson’s Disease Progressionhttps://reachmd.com/news/subcortical-shape-alterations-reveal-new-insights-into-parkinsons-disease-progression/2471375/Recent studies highlight the role of subcortical shape changes as potential markers for clinical staging in Parkinson's disease, offering novel avenues for diagnostics and treatment. Understanding Subcortical Changes Recent studies have
- Investigating Potential Ocular Risks of Weight-Loss Drugshttps://reachmd.com/news/investigating-potential-ocular-risks-of-weight-loss-drugs/2471333/Research conducted at the University of Utah's John A. Moran Eye Center explored potential vision complications in patients using semaglutide and tirzepatide, commonly prescribed weight-loss drugs. The review of nine cases suggests that rapid alterations in blood sugar level
- Innovative ALS Platform Trial: A New Approach to Drug Testinghttps://reachmd.com/news/innovative-als-platform-trial-a-new-approach-to-drug-testing/2471274/The HEALEY ALS Platform Trial marks a significant shift in how amyotrophic lateral sclerosis treatments are tested, promising faster and more cost-effective drug development. The HEALEY ALS Platform Trial represents a groundbreaking approach to
- Innovative Approaches in Cancer and Neurological Treatments: A New Era of Precision Medicinehttps://reachmd.com/news/innovative-approaches-in-cancer-and-neurological-treatments-a-new-era-of-precision-medicine/2471313/The latest developments in cancer treatment and brain activity visualization are paving the way for more personalized and effective healthcare solutions. Advancements in Cancer Therapies and Brain Activity Visualization Recent breakthro
- Curcumin's Role in Reducing Neuroinflammation: New Insights and Mechanismshttps://reachmd.com/news/curcumins-role-in-reducing-neuroinflammation-new-insights-and-mechanisms/2471242/Recent studies reveal how curcumin, a compound from turmeric, modulates neuroinflammation in epilepsy, offering new therapeutic avenues. Understanding the Role of Curcumin in Neuroinflammation Curcumin, a compound found in turmeric, is
- Beyond the Surface: Updates in Itch Treatmenthttps://reachmd.com/news/beyond-the-surface-updates-in-itch-treatment/2471285/
- Exploring CYP46A1's Role in Parkinson's Disease Progression: New Insights and Implicationshttps://reachmd.com/news/exploring-cyp46a1s-role-in-parkinsons-disease-progression-new-insights-and-implications/2471282/Recent studies have unveiled the significant role of cholesterol 24-hydroxylase CYP46A1 in promoting α-synuclein pathology, a hallmark of Parkinson's disease. This discovery opens up potential therapeutic pathways aimed at mitigating neurodegeneration.